Intellia Therapeutics Inc buy Wolfe Research
Start price
21.04.25
/
50%
€6.94
Target price
21.04.26
€18.30
Performance (%)
87.66%
End price
22.04.26
€13.02
Summary
This prediction ended on 22.04.26 with a price of €13.02. With a performance of 87.66% the BUY prediction by Wolfe_Research was a big success. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -4.970% | -4.970% | -15.436% |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by Wolfe_Research for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $21.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten